Edition:
United Kingdom

Alembic Pharma Gets U.S. FDA Nod For Generic Drug to Treat Overactive Bladder


Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Alembic Pharmaceuticals Ltd ::GETS U.S. FDA NOD FOR DARIFENACIN EXTENDED-RELEASE TABLETS.DRUG IS INTENDED TO TREAT OVERACTIVE BLADDER. 

Related Company News

Company Quote

567.7
2.45 +0.43%
9:59am GMT